Location History:
- Brookline, MA (US) (2002 - 2008)
- Pittsburgh, PA (US) (2009)
- Wellesley, MA (US) (2010 - 2016)
Company Filing History:
7 out of 517 
3 out of 80 
3 out of 1,386 
Years Active: 2002-2016
Title: Inventor Xin Xiao Zheng: Pioneering Advances in Immunology
Introduction
Xin Xiao Zheng, based in Wellesley, Massachusetts, is a remarkable inventor who has made significant contributions to the field of immunology. With a portfolio of ten patents, Zheng's innovative work focuses on modulating immune responses through the development of TIM-3 ligands.
Latest Patents
Zheng's latest patents revolve around "TIM-3 ligands and methods of modulating immune responses." The inventions relate to isolated polypeptides and nucleic acids encoding polypeptides that specifically comprise a TIM-3 IgV domain and a TIM-3 intracellular domain, intentionally excluding the TIM-3 mucin domain or transmembrane domain. Additionally, these patents include methods for modulating immune responses in a subject by administering a therapeutically effective amount of an agent that influences TIM-3 activity. The immune responses targeted by this invention encompass a wide range, including immune tolerance, transplantation tolerance, Th1 responses, and Th2 responses.
Career Highlights
Throughout her career, Xin Xiao Zheng has worked with prestigious organizations such as Bethesda Israel Deaconess Medical Center and The Beth Israel Hospital Association. Her contributions in these settings have further established her as a leading figure in her field, particularly in immunological research and application.
Collaborations
Zheng has collaborated with notable professionals in her field, including Terry Barton Strom and Alan Steele. These collaborations have allowed her to enhance her research capabilities and broaden the impact of her inventions on immune response modulation.
Conclusion
Xin Xiao Zheng exemplifies innovation in the field of immunology, with a focus on developing TIM-3 ligands and methods to modulate immune responses. Her ten patents reflect a deep commitment to advancing scientific understanding and practical applications in healthcare. As Zheng continues her work, her contributions will undoubtedly play a vital role in shaping the future of immunological therapies.